WASHINGTON - Teva Pharmaceuticals sued the Secretary of Health and Human Services and the FDA in Federal Court, demanding that they require clinical trials for "putative generic versions" of its multiple sclerosis drug Copaxon before approving them.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026